MedPath

Nintendo Wii Virtual Reality Application In Dementia

Not Applicable
Completed
Conditions
Age-Related Memory Disorders
Interventions
Other: Nintendo Wii Virtual Reality Application
Registration Number
NCT04819126
Lead Sponsor
Kırıkkale University
Brief Summary

•This study was planned to investigate the effects of the Nintendo Wii virtual reality application on muscle strength and fall risk in individuals with AD.

The aim of the present study is to investigate the effect of the virtual reality application on muscle strength and fall in individuals with Alzheimer' Dementia (AD).

Detailed Description

Purpose: This study was planned to investigate the effects of the Nintendo Wii virtual reality application on muscle strength and fall risk in individuals with AD.

Method: The study included a total of 32 volunteers between the ages of 65-80, with mild or moderate AD diagnosed. These individuals were divided into 2 groups as a training group and control group. The training group was trained with games from different categories such as balance and aerobic exercises with a Nintendo Wii virtual reality device 2 times a week for a period of 6 weeks, with 1 session lasting for 30 minutes. Mini-Mental State Test, Knee Extension Muscle Strength, Timed Up and Go Test, Tinetti Falls Efficacy Scale results of individuals were recorded in the evaluation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • included volunteers between the ages of 65-80 with mild or moderate AD diagnosis,
  • who did not have any difficulty or problems in communicating,
  • who did not have any neurological diseases that disrupt balance and coordination such as a cerebrovascular event, Parkinson's disease, Multiple Sclerosis, and neurological disorder,
  • who obtained a score of 18 - 24 points in the Mini-Mental State Test (MMST)
Exclusion Criteria
  • Patients diagnosed with rapidly progressing dementia (infection, vascular, hematologic diseases),
  • Those who could not be contacted during the follow-up period or who did not participate in the training session, those who experienced cardiac and cerebrovascular events, endocrine disorders, fluid-electrolyte imbalance and infection,
  • Those with malignancy and those who received chemotherapy and radiotherapy that causes malignancy, delirium or depression and malignant sensory loss (those with the Semmes-Weinstein monofilament thickness of 4.56 and above),
  • Those with a lower or upper extremity amputation at any level

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Nintendo Wii Virtual Reality Application In Older People With Alzheimer's DementiaNintendo Wii Virtual Reality ApplicationThe study included a total of 32 volunteers between the ages of 65-80, who stayed in Karaman Ahmet Mete Nursing Home, Elderly Care and Rehabilitation Center, with mild or moderate Alzheimer's dementia diagnosed by a neurologist. As a result of the power analysis, it was calculated that at least 16 individuals could be included in each group (at least 32 individuals in total). Randomization was performed by the sealed-envelope method. According to this method, 4 females and 12 males were determined to be in the control group, while 5 females and 11 males were determined to be in the training group. The evaluation was completed before the intervention. The same evaluation was conducted after 6 weeks. The training group was trained with games from different categories such as balance and aerobic exercises with a Nintendo Wii virtual reality device 2 times a week for a period of 6 weeks, with 1 session lasting for 30 minutes, and each patient was trained with the same games.
Primary Outcome Measures
NameTimeMethod
Sex/Genderperiod of 6 weeks

Sex: Female, Male

Age :mean or median ageperiod of 6 weeks

Age, Categorical:

\>=65 years

Body Mass Indexperiod of 6 weeks

BMI was recorded in kg/m\^2.

Secondary Outcome Measures
NameTimeMethod
The Mini-Mental State Test for Cognitive statusperiod of 6 weeks

According to the MMST, 24-30 points were considered as normal cognitive levels, 18-23 points were considered as mild cognitive disorders, and 0-17 points were considered as severe cognitive disorders

Trial Locations

Locations (1)

Karaman Ahmet Mete Nursing Home

🇹🇷

Konya, Turkey

© Copyright 2025. All Rights Reserved by MedPath